The $2.6 billion pill--methodologic and policy considerations

Affiliations

¹ From Harvard Medical School and the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital - both in Boston.

Jerry Avorn. N Engl J Med. 2015.

. 2015 May 14;372(20):1877-9.

doi: 10.1056/NEJMp1500848.

¹ From Harvard Medical School and the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital - both in Boston.

No abstract available

Comment in

The cost of drug development.
DiMasi JA, Grabowski HG, Hansen RW. DiMasi JA, et al. N Engl J Med. 2015 May 14;372(20):1972. doi: 10.1056/NEJMc1504317. N Engl J Med. 2015. PMID: 25970070 No abstract available.